The solid progress of nanomedicine
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Tipo de contenido
Journal Article
DeCS
grupos focales | nanomedicina | humanos | neoplasias | National Cancer Institute (U.S.)MeSH
National Cancer Institute (U.S.) | Humans | Nanomedicine | Focus Groups | NeoplasmsResumen
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.
![](/xmlui/themes/Mirage2//images/final_lines.png)